Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(11):26 Behav Brain Res. 1996 11-Apr;():. 10.1016/0166-4328(96)00102-7What this means for my practice?
The chronic use of tricyclic antidepressants and lithium resulted in subjective increases in the effects of LSD, while the chronic use of MAO inhibitors resulted in subjective decreases in LSD effects.
Study Summary
In this retrospective cohort study, 10 patients who used LSD during a period of chronic (3 weeks or longer) antidepressant administration were asked to recall the effects of hallucinogens while on, and when not on antidepressants. A semi-structured interview with a standard questionnaire regarding the effects of LSD was used for all patients. Chronic use of tricyclic antidepressants and lithium was associated with increased responses to LSD, while patients with chronic monoamine oxidase (MAO) inhibitors reported subjective decreases in LSD effects.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!